
Mirugen – Unlocking the Power of Retina Regeneration
Mirugen – Unlocking the Power of Retina Regeneration
Search results
Mirugen – Unlocking the Power of Retina Regeneration
Several groups around the world are investigating the use of retinal transplantation in the treatment of inherited retinal diseases.
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
Retina UK aims not only to progress research along established threads, but to stimulate new thinking, encourage innovative approaches and nurture original ideas.
Funding from Retina UK has allowed to team to explore the viability of gene therapy as a treatment for RP and related conditions, and build a pipeline of clinical trials.
The following projects were being funded by Retina UK and have recently come to an end.
Researchers who received funding from Retina UK have carried out experimental gene therapy that is reported to have led to ‘life changing improvements’ to sight for four children with inherited sight loss.
Giving a regular monthly or quarterly donation of any amount is a wonderful way to help Retina UK support the inherited sight loss community.